Dose-response curve slope is a missing dimension in the analysis of HIV-1 drug resistance

HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance

(2010) S.-Y. Rhee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Instantaneous Inhibitory Potential and Inhibitory Quotient Show a Modest Association with Virologic Outcome: Is Either a Useful Surrogate for Clinical Drug Efficacy?

(2010) Rodger D. MacArthur   CLINICAL INFECTIOUS DISEASES

Instantaneous Inhibitory Potential Is Similar to Inhibitory Quotient at Predicting HIV‐1 Response to Antiretroviral Therapy

(2010) Timothy J. Henrich et al.   CLINICAL INFECTIOUS DISEASES

Achieving a Quantitative Understanding of Antiretroviral Drug Efficacy

(2010) Lin Shen et al.   CLINICAL INFECTIOUS DISEASES

Antiretroviral medication adherence and the development of class-specific antiretroviral resistance

(2009) Edward M Gardner et al.   AIDS

Biochemical Analysis of HIV-1 Integrase Variants Resistant to Strand Transfer Inhibitors

(2008) Ira B. Dicker et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sensitivity of Phenotypic Susceptibility Analyses for Nonthymidine Nucleoside Analogues Conferred by K65R or M184V in Mixtures with Wild-Type HIV-1

(2008) Mark R. Underwood et al.   JOURNAL OF INFECTIOUS DISEASES

Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs

(2008) Lin Shen et al.   NATURE MEDICINE